Paper9780252
Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring.
Moodley J and 11 others. J Infect Dis, 1998. Cited by 152 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring. Papers, record 9780252. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9780252
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-HIV Agents | Major topic |
| HIV Infections | Major topic |
| HIV-1 | Major topic |
| Infectious Disease Transmission, Vertical | Major topic |
| Lamivudine | Major topic |
| Zidovudine | Major topic |
| Administration, Oral | |
| Adolescent | |
| Adult | |
| Amniotic Fluid | |
| Black People | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Infant, Newborn | |
| Milk, Human | |
| Pregnancy | |
| RNA, Viral | |
| Random Allocation | |
| South Africa | |
| Viral Load |
Source PubMed
Cited by55
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 152 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41983686 | Physiologically-based pharmacokinetic modelling of uridine 5'-diphosphoglucorosultransferase (UGT) substrate drugs in pregnant women. | Br J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/41983686 | PubMed |
| 41904696 | Exposure to Frontline Antiretroviral Dolutegravir Disrupts Oligodendrocyte Development Across Differentiation Stages. | ASN Neuro | 2026 | https://conductscience.org/library/papers/41904696 | PubMed |
| 39652285 | Role of Dolutegravir/Lamivudine in the Management of Pregnant People Living with HIV-1: A Narrative Review. | Infect Dis Ther | 2025 | https://conductscience.org/library/papers/39652285 | PubMed |
| 37116934 | Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV. | Glob Health Sci Pract | 2023 | https://conductscience.org/library/papers/37116934 | PubMed |
| 35067869 | Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach. | Clin Pharmacokinet | 2022 | https://conductscience.org/library/papers/35067869 | PubMed |
| 32631820 | Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/32631820 | PubMed |
| 31912985 | Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading? | J Int AIDS Soc | 2020 | https://conductscience.org/library/papers/31912985 | PubMed |
| 29369162 | Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV. | AIDS | 2018 | https://conductscience.org/library/papers/29369162 | PubMed |
| 28426519 | Toward a universal antiretroviral regimen: special considerations of pregnancy and breast feeding. | Curr Opin HIV AIDS | 2017 | https://conductscience.org/library/papers/28426519 | PubMed |
| 28212307 | Antiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free Children. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28212307 | PubMed |
| 28079918 | Dose evaluation of lamivudine in human immunodeficiency virus-infected children aged 5 months to 18 years based on a population pharmacokinetic analysis. | Br J Clin Pharmacol | 2017 | https://conductscience.org/library/papers/28079918 | PubMed |
| 26492107 | Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy. | Antivir Ther | 2016 | https://conductscience.org/library/papers/26492107 | PubMed |
| 26431339 | Development of Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Indomethacin Disposition in Pregnancy. | PLoS One | 2015 | https://conductscience.org/library/papers/26431339 | PubMed |
| 25959631 | Pharmacokinetics of tenofovir during pregnancy and postpartum. | HIV Med | 2015 | https://conductscience.org/library/papers/25959631 | PubMed |
| 25858354 | Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies. | J Antimicrob Chemother | 2015 | https://conductscience.org/library/papers/25858354 | PubMed |
| 25755458 | Chronic hepatitis B virus infection and pregnancy. | J Clin Exp Hepatol | 2012 | https://conductscience.org/library/papers/25755458 | PubMed |
| 25223699 | Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals. | Clin Pharmacokinet | 2014 | https://conductscience.org/library/papers/25223699 | PubMed |
| 25040510 | Maternal and fetal zidovudine pharmacokinetics during pregnancy and labour: too high dose infused at labour? | Br J Clin Pharmacol | 2014 | https://conductscience.org/library/papers/25040510 | PubMed |
| 24322269 | Drug labeling and exposure in neonates. | JAMA Pediatr | 2014 | https://conductscience.org/library/papers/24322269 | PubMed |
| 23563007 | Efficacy of telbivudine on interruption of hepatitis B virus vertical transmission: a meta-analysis. | Ann Saudi Med | 2013 | https://conductscience.org/library/papers/23563007 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9780252
GET https://conductscience.org/api/papers/v1/9780252/cited_by?page=2